Associate Professor @UniversitySA 🇦🇺 Translational Cancer Researcher; almost exclusively on https://xitter.cf/t.co/rSaEHPOza8!
Adelaide, Australia
Joined October 2018
- Tweets584
- Following395
- Followers424
- Likes2K
Our latest review article is now available online: ‘The RB protein: More than a sentry of cell cycle entry’. authors.elsevier.com/a/1k-zt… @FarzanehForouz @dray_lab @CCB_Research @UniversitySA
Pascal Duijf retweeted
Excited to share our latest publication in Cell Reports where we reveal the critical role of SRBD1 in mitotic chromosome segregation.
Read more here: tinyurl.com/y9cfkw4h
A big thanks to all our wonderful collaborators - This wouldn't have been possible without you!
Pascal Duijf retweeted
1/ 🚨New paper on ecDNAs from our lab!
We reveal a strategy to engineer extrachromosomal DNA (ecDNA) amplifications in cells & mice. Let's dive in!
🧵👇
nature.com/articles/s41586-0…
Pascal Duijf retweeted
Check it out the preview of our mechano aneuploidy response paper that will be released early January. A great sneak peek from @ELogarinho team nature.com/articles/s41556-0…
Pascal Duijf retweeted
I am recruiting postdocs with experience in cancer cell biology and advanced molecular biology. If you are passionate about gene regulation, RNA splicing, and using CRISPR tools to understand how these processes impact cancer progression contact me for more info. @CCB_Research
Pascal Duijf retweeted
This manuscript is now published in the @CytoskelJournal Special Issue: Myosin and Myosin-Dependent Cell Processes. Volume 81, Issue 12 doi.org/10.1002/cm.21894
Happy to be involved in this latest study from our lab, "Enhanced RHO-ROCK signaling is associated with CRELD2 production and fibroblast recruitment in cutaneous squamous cell carcinoma" onlinelibrary.wiley.com/doi/…
@CCB_Research @UniversitySA
Pascal Duijf retweeted
New R package from @jackierao_ @MRC_BSU implementing variational Bayesian finite mixture models to cluster categorical data, with variable selection and semi-supervised outcome guiding if desired. cran.r-project.org/web/packa…
Pascal Duijf retweeted
Nice to see this paper from the Gabrielli lab finally out:
nature.com/articles/s41419-0…
Pascal Duijf retweeted
Excited to share my latest research in immunodeficiencies! We’ve uncovered the impact of IKKα kinase deficiency in humans for the first time. Huge thanks to all co-authors for their contributions. @CCB_Research @UniversitySA @unisaresearch nature.com/articles/s41467-0…
Pascal Duijf retweeted
Please repost!
PhD scholarship @molregulation !
Interested in discovery research in the cell biology of extracellular vesicles (EVs)? We have an exciting @arc_gov_au-funded project for a PhD student.
@CCB_Research @unisaresearch @ANZSEVresearch @ANZSCDB
We are looking for a postdoctoral fellow! Apply by Sunday 3 November, if you are interested 🙂 workingatunisa.nga.net.au/cp…
Pascal Duijf retweeted
Honoured to receive the Viertel Senior Medical Research Fellowship for my work on epigenetic regulation in cancer at @SAiGENCI @ACEpigenetics @UniofAdelaide! Thank you to the Viertel Foundation and my incredible mentors! bit.ly/48k2Yr5
Pascal Duijf retweeted
Congrats to @rubicamposg and team for their article in @BrJCancer showing that EMI1 regulates chromosome stability and discussing how its abnormal expression impacts #cancer development: rdcu.be/dVL0m
Support from: @CRSNG_NSERC @SRC_CRS @QuIPS_Platform @CancerCareMBFdn
Pascal Duijf retweeted
Our Review on “Aneuploidy as a driver of human cancer” is out in Nature Genetics. Check it out! 🎉
The Ben-David lab wishes everyone Shana Tova — may the new year be much better than the ending one, bringing peace and stability to all! 🙏
nature.com/articles/s41588-0…
Pascal Duijf retweeted
Excited to share that our study on generating a humanized DMD mouse model using CRISPR has been published! This model will be instrumental in advancing research for potential therapies. Huge thanks to the team for their dedication! #CRISPR #DMD #Research
bmcbiol.biomedcentral.com/ar…
Pascal Duijf retweeted
Excited to share our review on #genomic testing for children, adolescents & young adults with #Cancer
- 16-18% germline variant - 40% de novo
- CNVs ++ than in adults
- 18-69% have variant with a matched therapy - 1/3 receive it.
@CancerAustralia
track.smtpsendmail.com/90321…
Pascal Duijf retweeted
Super excited to share that we’ve moved to Yale University’s Department of Urology to continue our prostate cancer research. Already loving the Yale community and looking forward to some awesome collaborations ahead. @Yale_Urology @YaleMed @YaleCancer @Yale
Pascal Duijf retweeted
We are recruiting! Come join us in Adelaide to work on cutting-edge translational research and contribute to developing CAR-T cell therapies for brain tumours. Two post-doc positions available, closing soon, details at careers.pageuppeople.com/532…
Pascal Duijf retweeted
Very happy to share our latest papers on the identification of novel dependencies of aneuploid cells just published in @NatureComms and @CD_AACR!🧬A work jointly conceived by @BenDavidLab and @SteSantaguida and beautifully executed by talented @JohannaZrb and @MaricaIppolito 👇
Pascal Duijf retweeted
Thrilled to share our new paper in @ScienceMagazine, in which we identify p62/SQSTM1 as a critical regulator of micronuclei 🧬🔬🧫 #ScienceResearch
science.org/doi/10.1126/scie…
